← Eichor
Study identifier: NCT05898932 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

Condition: Benign Prostatic Hyperplasia  ·  Sponsor: Northwestern University

PhaseN/A
Planned participants300
Who can joinMale, 50 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this project is to use newly developed patient-reported outcomes to improve the clinical care of patients with benign prostatic hyperplasia. The use of new patient-centered tools will improve evaluation and clinical decision-making by including symptoms not commonly measured in men, such as urinary incontinence, and allow for more frequent assessment of lower urinary tract symptoms through remote surveillance. Through the use of care-coordination checklists, clinicians can be more responsive to post-treatment symptom changes, resulting in reduced bother from lower urinary tract symptoms and higher quality of life in patients with benign prostatic hyperplasia.

This description comes directly from the study's public registry record.

Talk to the study team

Dacey Maglaque  ·  847-503-4278  ·  dmaglaque2@northshore.org

Pooja Talaty  ·  847-503-4280  ·  PTalaty@northshore.org

Always discuss trial participation with your own doctor first.

Locations (1)

NorthShore University HealthSystem Research InstituteGlenview, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05898932